Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar 30;122(7):1006-1020.
doi: 10.1161/CIRCRESAHA.117.312486.

Preclinical Studies of Stem Cell Therapy for Heart Disease

Affiliations
Review

Preclinical Studies of Stem Cell Therapy for Heart Disease

Bryon A Tompkins et al. Circ Res. .

Abstract

As part of the TACTICS (Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes) series to enhance regenerative medicine, here, we discuss the role of preclinical studies designed to advance stem cell therapies for cardiovascular disease. The quality of this research has improved over the past 10 to 15 years and overall indicates that cell therapy promotes cardiac repair. However, many issues remain, including inability to provide complete cardiac recovery. Recent studies question the need for intact cells suggesting that harnessing what the cells release is the solution. Our contribution describes important breakthroughs and current directions in a cell-based approach to alleviating cardiovascular disease.

Keywords: heart failure; infarction; regenerative medicine; stem cells.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Procurement and isolation of MSCs
MSCs isolated from bone marrow and the mononuclear cells isolated by Ficoll density centrifugation. MSCs can be separated from other mononuclear cells by their plastic adherence in culture. From Williams and Hare
Figure 2.
Figure 2.. Combination CSC/MSC.
Preload, afterload, and contractility changes after human cardiac stem cells (hCSC) and human mesenchymal stem cell (hMSCs). A. Left ventricular end-diastolic pressure (LVEDP) and (B) end-diastolic volume (EDV) and afterload measured by (C) arterial elastance (Ea). Combination hCSC/hMSC therapy improved contractility as measured by the (D) maximal rate of pressure change during systole (dP/dtmax) and (E) preload recruitable stroke work (PRSW), a preload-independent measure of stroke work. There was no change in (F) systolic elastance (Ees), in any of the groups. All graphs show pre-injection (2 weeks post-MI) vs 4-week post-injection values. Graphs represent mean±SEM. *P<0.05. From Williams et al..
Figure 3.
Figure 3.. Different administration routes and cell types for treatment of heart disease.
The cell types listed under each delivery method refer only to those referenced (superscripted number) in this review. Figure adapted from Golpanian et al.

Similar articles

Cited by

References

    1. Fernández-Avilés F, Sanz-Ruiz R, Climent AM, et al. Global position paper on cardiovascular regenerative medicine. Eur Heart J. 2017;38:2532–2546. - PMC - PubMed
    1. Fernández-Avilés F, Sanz-Ruiz R, Climent AM, et al. Global Overview of the Transnational Alliance for Regenerative Therapies in Cardiovascular Syndromes (TACTICS) Recommendations. A Comprehensive Series of Challenges and Priorities of Cardiovascular Regenerative Medicine. Circ Res. 2017. - PubMed
    1. Writing Group M, Mozaffarian D, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38–360. - PubMed
    1. Gyongyosi M, Wojakowski W, Lemarchand P, et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res. 2015;116:1346–60. - PMC - PubMed
    1. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981–8. - PubMed

Publication types

MeSH terms